Search for Clinical Trial Results

Sponsored By

Hemoglobinuria, Paroxysmal - 24 Studies Found

Status Study
Completed Study Name: Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Condition: Hemoglobinuria, Paroxysmal
Date: 2010-10-18
Completed Study Name: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects
Condition: Hemoglobinuria, Paroxysmal
Date: 2009-03-23
Interventions: Drug: Eculizumab Other Name: Soliris
Completed Study Name: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Condition: Hemoglobinuria, Paroxysmal
Date: 2008-07-23
Approved for marketing Study Name: The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
Condition: Hemoglobinuria, Paroxysmal
Date: 2007-02-20
Interventions: Drug: eculizumab 600mg IV every week and 900mg IV every 2 weeks
Completed Study Name: Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Condition: Hemoglobinuria, Paroxysmal
Date: 2005-07-18
Interventions: Drug: eculizumab
Completed Study Name: Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
Condition: Hemoglobinuria, Paroxysmal
Date: 2005-07-19
Interventions: Drug: eculizumab
Completed Study Name: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Date: 2005-08-11
Interventions: Drug: Eculizumab
Completed Study Name: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria
Date: 2002-06-14
Recruiting Study Name: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Date: 2016-11-01
Interventions:
  • Drug: RO7112689 RO7112689 will
Completed Study Name: Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Date: 2005-07-20
Interventions:
  • Drug: eculizumab 600 mg intrav
Next >>>